Short Interest in CNBX Pharmaceuticals Inc. (OTCMKTS:CNBX) Decreases By 100.0%

CNBX Pharmaceuticals Inc. (OTCMKTS:CNBX) was the recipient of a significant decline in short interest in July. As of July 15th, there was short interest totaling 1 shares, a decline of 100.0% from the June 30th total of 283,205 shares. Based on an average daily volume of 92,742,631 shares, the short-interest ratio is currently 0.0 days.

CNBX Pharmaceuticals Trading Up 100.0%

Shares of CNBX Pharmaceuticals stock traded up $0.00 during trading on Friday, hitting $0.00. 12,009,403 shares of the stock traded hands, compared to its average volume of 33,205,117. CNBX Pharmaceuticals has a twelve month low of $0.00 and a twelve month high of $0.00.

CNBX Pharmaceuticals Company Profile

CNBX Pharmaceuticals Inc is a clinical-stage pharmaceutical company focused on the research and development of synthetic cannabinoid-based drug candidates. The company’s proprietary platform applies medicinal chemistry techniques to design novel small-molecule analogs of naturally occurring cannabinoids, aiming to improve efficacy and safety compared with existing therapies. Its pipeline includes multiple preclinical compounds targeting neuropathic and chronic pain, with a goal of advancing these candidates through IND-enabling studies.

Headquartered in Costa Mesa, California, CNBX Pharmaceuticals collaborates with contract research organizations and academic partners to conduct pharmacology and toxicology studies as well as scale up manufacturing processes.